RevMedx
Wilsonville, US · Oregon corporation
RevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
Defense TechHealthtechMedical Devices
Founders & leadership
AD
Andrew D. BarofskyExecutive
SD
Shari D. BekeExecutive
KW
Kenton W. GregoryNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2016
▶$3.5MraisedMar 2016 · 2 investors · OtherRule 506(b)
▶$3.5MraisedMar 2016 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kenton W. GregoryExecutive Officer, Director
- Andrew D. BarofskyExecutive Officer, Director
- Shari D. BekeExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $3.5M
- First sale
- Feb 2016
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with RevMedx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does RevMedx do?
- RevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
- How much funding has RevMedx raised?
- RevMedx has disclosed $3.5M raised across 1 round.
- Where is RevMedx headquartered?
- RevMedx is headquartered in Wilsonville, US.